Comparison of E test and agar dilution for testing activity of ceftriaxone against Neisseria gonorrhoeae

References

1. Bala M., Kakran M., Singh V., Sood S., Ramesh V. Members of the WHO GASP SEAR Network 2013; Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infec 89:iv28–iv35 [View Article]
   [Google Scholar]
2. Bell S. M., Pham J. N., Carter I. W., Hanrahan J. K. 2011 Antibiotic Susceptibility Testing by the CDS Method. A Manual for Medical and Veterinary Laboratories, 6th edn. Randwick, NSW: South Eastern Area Laboratory Services;
   [Google Scholar]
3. CDC 2015; Sexually transmitted diseases treatment guidelines. MMWR 64:1–140
   [Google Scholar]
4. CLSI 2012 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, 9th edn, M07-A9 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. Ison C., Hussey J., Sankar K., Evans J., Alexander S. 2011; Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 16:19833
   [Google Scholar]
6. Lahra M. M., Ryder N., Whiley D. M. 2014; A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med 371:1850–1851 [View Article][PubMed]
   [Google Scholar]
7. Martin I. M., Hoffmann S., Ison C. A. ESSTI Network 2006; European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 58:587–593 [View Article][PubMed]
   [Google Scholar]
8. Ohnishi M., Golparian D., Shimuta K., Saika T., Hoshina S., Iwasaku K., Nakayama S., Kitawaki J., Unemo M. 2011; Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55:3538–3545 [View Article]
   [Google Scholar]
9. Sood S., Mahajan N., Verma R., Kar H. K., Sharma V. K. 2013; Emergence of decreased susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae in India. Natl Med J India 26:26–28[PubMed]
   [Google Scholar]
10. U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Devices and Radiological Health 2009 Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) System Rockville, MD http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080564
    [Google Scholar]
11. Unemo M., Fasth O., Fredlund H., Limnios A., Tapsall J. 2009; Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 63:1142–1151 [View Article][PubMed]
    [Google Scholar]
12. Unemo M., Golparian D., Syversen G., Vestrheim D. F., Moi H. 2010; Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 15:19721[PubMed] [Crossref]
    [Google Scholar]